Silencing KRAS Overexpression in Arsenic-Transformed Prostate Epithelial and Stem Cells Partially Mitigates Malignant Phenotype
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Silencing KRAS Overexpression in Arsenic-Transformed Prostate Epithelial and Stem Cells Partially Mitigates Malignant Phenotype
Authors
Keywords
-
Journal
TOXICOLOGICAL SCIENCES
Volume 142, Issue 2, Pages 489-496
Publisher
Oxford University Press (OUP)
Online
2014-10-02
DOI
10.1093/toxsci/kfu201
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Cancer statistics, 2014
- (2014) Rebecca Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Aberrant microRNA Expression Likely Controls RAS Oncogene Activation During Malignant Transformation of Human Prostate Epithelial and Stem Cells by Arsenic
- (2014) Ntube N. O. Ngalame et al. TOXICOLOGICAL SCIENCES
- Androgens and prostate cancer; pathogenesis and deprivation therapy
- (2013) Mathis Grossmann et al. BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM
- miR-205 negatively regulates the androgen receptor and is associated with adverse outcome of prostate cancer patients
- (2013) Z Hagman et al. BRITISH JOURNAL OF CANCER
- Mutant KRAS is a druggable target for pancreatic cancer
- (2013) E. Zorde Khvalevsky et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Distinct microRNA Expression Profiles in Prostate Cancer Stem/Progenitor Cells and Tumor-Suppressive Functions of let-7
- (2012) C. Liu et al. CANCER RESEARCH
- MiR-130a, miR-203 and miR-205 jointly repress key oncogenic pathways and are downregulated in prostate carcinoma
- (2012) K Boll et al. ONCOGENE
- Systematic Analysis of MicroRNAs Targeting the Androgen Receptor in Prostate Cancer Cells
- (2011) P. Ostling et al. CANCER RESEARCH
- Combined point mutations in codon 12 and 13 of KRAS oncogene in prostate carcinomas
- (2011) Fatma Silan et al. MOLECULAR BIOLOGY REPORTS
- Knockdown of Oncogenic KRAS in Non-Small Cell Lung Cancers Suppresses Tumor Growth and Sensitizes Tumor Cells to Targeted Therapy
- (2011) N. Sunaga et al. MOLECULAR CANCER THERAPEUTICS
- Matrix Metalloproteinases: Regulators of the Tumor Microenvironment
- (2010) Kai Kessenbrock et al. CELL
- Matrix Metalloproteinase-Induced Epithelial-Mesenchymal Transition in Breast Cancer
- (2010) Evette S. Radisky et al. JOURNAL OF MAMMARY GLAND BIOLOGY AND NEOPLASIA
- Arsenic-induced malignant transformation of human keratinocytes: Involvement of Nrf2
- (2008) Jingbo Pi et al. FREE RADICAL BIOLOGY AND MEDICINE
- Ras oncogenes: split personalities
- (2008) Antoine E. Karnoub et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Inorganic Arsenic and Human Prostate Cancer
- (2007) Lamia Benbrahim-Tallaa et al. ENVIRONMENTAL HEALTH PERSPECTIVES
- Matrix metalloproteinases at cancer tumor–host interface
- (2007) A NOEL et al. SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More